{"id":2789,"date":"2020-01-10T11:54:28","date_gmt":"2020-01-10T10:54:28","guid":{"rendered":"http:\/\/consult.taga.net\/?p=2789"},"modified":"2020-09-03T12:43:48","modified_gmt":"2020-09-03T11:43:48","slug":"change-management-in-pharmaceutical-firms-the-sanofi-model","status":"publish","type":"post","link":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/","title":{"rendered":"LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI"},"content":{"rendered":"<p>Disponible en castell\u00e0.<\/p>\n<p><strong>Resumen<\/strong>: Dennis Urbaniak, que fue Vicepresidente en US de la divisi\u00f3n de\u00a0Diabetes realiz\u00f3 cambios importantes en el enfoque de negocio y de la\u00a0innovaci\u00f3n en esta importante divisi\u00f3n de negocio. Su gesti\u00f3n fue en 2012 pero\u00a0sus aprendizajes son valiosos y muy vigentes hoy en la industria farmac\u00e9utica\u00a0en Europa y especialmente en Espa\u00f1a. Antes de hablar de sus aprendizajes,\u00a0hagamos unos comentarios sobre la industria en Espa\u00f1a.<\/p>\n<p>Art\u00edculo disponible en PDF:\u00a0\u00a0<a href=\"https:\/\/consult.taga.net\/wp-content\/uploads\/2020\/06\/7.-Gesti\u00f3n-del-Cambio-en-empresas-farmac\u00e9uticas.pdf\">La Gesti\u00f3n del Cambio en empresas farmac\u00e9uticas: el modelo SANOFI<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Disponible en castell\u00e0. Resumen: Dennis Urbaniak, que fue Vicepresidente en US de la divisi\u00f3n de\u00a0Diabetes realiz\u00f3 cambios importantes en el enfoque de negocio y de la\u00a0innovaci\u00f3n en esta importante divisi\u00f3n de negocio. Su gesti\u00f3n fue en 2012 pero\u00a0sus aprendizajes son valiosos y muy vigentes hoy en la industria farmac\u00e9utica\u00a0en Europa y especialmente en Espa\u00f1a. Antes&#8230;<\/p>\n","protected":false},"author":1,"featured_media":2791,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[1],"tags":[145,153,148,146],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.12 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI - Taga<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:ca]LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI[:es]LA GESTI\u00d3N DEL CAMBIO EN LAS EMPRESAS FARMAC\u00c9UTICAS: EL MODELO SANOFI[:en]CHANGE MANAGEMENT IN PHARMACEUTICAL FIRMS: THE SANOFI MODEL[:] - Taga\" \/>\n<meta property=\"og:description\" content=\"Disponible en castell\u00e0. Resumen: Dennis Urbaniak, que fue Vicepresidente en US de la divisi\u00f3n de\u00a0Diabetes realiz\u00f3 cambios importantes en el enfoque de negocio y de la\u00a0innovaci\u00f3n en esta importante divisi\u00f3n de negocio. Su gesti\u00f3n fue en 2012 pero\u00a0sus aprendizajes son valiosos y muy vigentes hoy en la industria farmac\u00e9utica\u00a0en Europa y especialmente en Espa\u00f1a. Antes...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\" \/>\n<meta property=\"og:site_name\" content=\"Taga\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-10T10:54:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-03T11:43:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/consult.taga.net\/wp-content\/uploads\/2020\/06\/retall.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1534\" \/>\n\t<meta property=\"og:image:height\" content=\"948\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"taga\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"taga\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\"},\"author\":{\"name\":\"taga\",\"@id\":\"https:\/\/consult.taga.net\/ca\/#\/schema\/person\/a45c66a946c453600b5a607d99fa25a6\"},\"headline\":\"LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI\",\"datePublished\":\"2020-01-10T10:54:28+00:00\",\"dateModified\":\"2020-09-03T11:43:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/#organization\"},\"keywords\":[\"Desenvolupament Empresarial\",\"Gesti\u00f3 del Canvi\",\"Gesti\u00f3 del talent\",\"Innovaci\u00f3\"],\"articleSection\":[\"Sin categor\u00eda\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\",\"url\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\",\"name\":\"[:ca]LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI[:es]LA GESTI\u00d3N DEL CAMBIO EN LAS EMPRESAS FARMAC\u00c9UTICAS: EL MODELO SANOFI[:en]CHANGE MANAGEMENT IN PHARMACEUTICAL FIRMS: THE SANOFI MODEL[:] - Taga\",\"isPartOf\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/#website\"},\"datePublished\":\"2020-01-10T10:54:28+00:00\",\"dateModified\":\"2020-09-03T11:43:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/consult.taga.net\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/consult.taga.net\/ca\/#website\",\"url\":\"https:\/\/consult.taga.net\/ca\/\",\"name\":\"Taga\",\"description\":\"Leadership, Strategy, Culture\",\"publisher\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/consult.taga.net\/ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/consult.taga.net\/ca\/#organization\",\"name\":\"Taga - Change Management\",\"url\":\"https:\/\/consult.taga.net\/ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/consult.taga.net\/ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/consult.taga.net\/wp-content\/uploads\/2019\/11\/Logo_change-management.png\",\"contentUrl\":\"https:\/\/consult.taga.net\/wp-content\/uploads\/2019\/11\/Logo_change-management.png\",\"width\":122,\"height\":68,\"caption\":\"Taga - Change Management\"},\"image\":{\"@id\":\"https:\/\/consult.taga.net\/ca\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/consult.taga.net\/ca\/#\/schema\/person\/a45c66a946c453600b5a607d99fa25a6\",\"name\":\"taga\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/consult.taga.net\/ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7b51dde4de9a188ac81546e9d7c9a4c9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7b51dde4de9a188ac81546e9d7c9a4c9?s=96&d=mm&r=g\",\"caption\":\"taga\"},\"url\":\"https:\/\/consult.taga.net\/ca\/author\/taga\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:ca]LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI[:es]LA GESTI\u00d3N DEL CAMBIO EN LAS EMPRESAS FARMAC\u00c9UTICAS: EL MODELO SANOFI[:en]CHANGE MANAGEMENT IN PHARMACEUTICAL FIRMS: THE SANOFI MODEL[:] - Taga","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/","og_locale":"ca_ES","og_type":"article","og_title":"[:ca]LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI[:es]LA GESTI\u00d3N DEL CAMBIO EN LAS EMPRESAS FARMAC\u00c9UTICAS: EL MODELO SANOFI[:en]CHANGE MANAGEMENT IN PHARMACEUTICAL FIRMS: THE SANOFI MODEL[:] - Taga","og_description":"Disponible en castell\u00e0. Resumen: Dennis Urbaniak, que fue Vicepresidente en US de la divisi\u00f3n de\u00a0Diabetes realiz\u00f3 cambios importantes en el enfoque de negocio y de la\u00a0innovaci\u00f3n en esta importante divisi\u00f3n de negocio. Su gesti\u00f3n fue en 2012 pero\u00a0sus aprendizajes son valiosos y muy vigentes hoy en la industria farmac\u00e9utica\u00a0en Europa y especialmente en Espa\u00f1a. Antes...","og_url":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/","og_site_name":"Taga","article_published_time":"2020-01-10T10:54:28+00:00","article_modified_time":"2020-09-03T11:43:48+00:00","og_image":[{"width":1534,"height":948,"url":"https:\/\/consult.taga.net\/wp-content\/uploads\/2020\/06\/retall.jpg","type":"image\/jpeg"}],"author":"taga","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"taga","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#article","isPartOf":{"@id":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/"},"author":{"name":"taga","@id":"https:\/\/consult.taga.net\/ca\/#\/schema\/person\/a45c66a946c453600b5a607d99fa25a6"},"headline":"LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI","datePublished":"2020-01-10T10:54:28+00:00","dateModified":"2020-09-03T11:43:48+00:00","mainEntityOfPage":{"@id":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/consult.taga.net\/ca\/#organization"},"keywords":["Desenvolupament Empresarial","Gesti\u00f3 del Canvi","Gesti\u00f3 del talent","Innovaci\u00f3"],"articleSection":["Sin categor\u00eda"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/","url":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/","name":"[:ca]LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI[:es]LA GESTI\u00d3N DEL CAMBIO EN LAS EMPRESAS FARMAC\u00c9UTICAS: EL MODELO SANOFI[:en]CHANGE MANAGEMENT IN PHARMACEUTICAL FIRMS: THE SANOFI MODEL[:] - Taga","isPartOf":{"@id":"https:\/\/consult.taga.net\/ca\/#website"},"datePublished":"2020-01-10T10:54:28+00:00","dateModified":"2020-09-03T11:43:48+00:00","breadcrumb":{"@id":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/consult.taga.net\/ca\/change-management-in-pharmaceutical-firms-the-sanofi-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/consult.taga.net\/ca\/"},{"@type":"ListItem","position":2,"name":"LA GESTI\u00d3 DEL CANVI EN LES EMPRESES FARMAC\u00c8UTIQUES: EL MODEL SANOFI"}]},{"@type":"WebSite","@id":"https:\/\/consult.taga.net\/ca\/#website","url":"https:\/\/consult.taga.net\/ca\/","name":"Taga","description":"Leadership, Strategy, Culture","publisher":{"@id":"https:\/\/consult.taga.net\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/consult.taga.net\/ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/consult.taga.net\/ca\/#organization","name":"Taga - Change Management","url":"https:\/\/consult.taga.net\/ca\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/consult.taga.net\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/consult.taga.net\/wp-content\/uploads\/2019\/11\/Logo_change-management.png","contentUrl":"https:\/\/consult.taga.net\/wp-content\/uploads\/2019\/11\/Logo_change-management.png","width":122,"height":68,"caption":"Taga - Change Management"},"image":{"@id":"https:\/\/consult.taga.net\/ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/consult.taga.net\/ca\/#\/schema\/person\/a45c66a946c453600b5a607d99fa25a6","name":"taga","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/consult.taga.net\/ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7b51dde4de9a188ac81546e9d7c9a4c9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7b51dde4de9a188ac81546e9d7c9a4c9?s=96&d=mm&r=g","caption":"taga"},"url":"https:\/\/consult.taga.net\/ca\/author\/taga\/"}]}},"_links":{"self":[{"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/posts\/2789"}],"collection":[{"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/comments?post=2789"}],"version-history":[{"count":3,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/posts\/2789\/revisions"}],"predecessor-version":[{"id":2794,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/posts\/2789\/revisions\/2794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/media\/2791"}],"wp:attachment":[{"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/media?parent=2789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/categories?post=2789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/consult.taga.net\/ca\/wp-json\/wp\/v2\/tags?post=2789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}